Claire.Fukutaki

About Claire Fukutaki

This author has not yet filled in any details.
So far Claire Fukutaki has created 67 blog entries.

Amy Trejo

2018-08-29T04:39:48-07:00

Amy Trejo, Open Innovation Manager at Procter & Gamble Dr. Amy Trejo works for the multi-national consumer products company, Procter & Gamble, maker of household products including Tide, Pampers, Pantene and Crest.  She received her BSc. in Biology from Smith College in Northampton, MA and PhD in Cell and Molecular Biology from Northwestern [...]

Amy Trejo2018-08-29T04:39:48-07:00

Maria Soloveychik

2018-06-11T12:32:15-07:00

Maria Soloveychik, Co-Founder and CEO of SyntheX Maria Soloveychik is the co-founder and CEO of SyntheX, a therapeutics company focused on accelerating drug discovery using synthetic biology. The company’s core technology, ToRPPIDO, relies on genetic engineering and evolutionary selection to synthesize and identify compounds which modulate protein-protein interactions. SyntheX was founded in [...]

Maria Soloveychik2018-06-11T12:32:15-07:00

Jon Entine

2018-06-11T09:27:00-07:00

Jon Entine, Founder of the Genetic Literacy Project Jon Entine is founder and executive director of the Genetic Literacy Project, an online-based resource and conference outreach program focused on biomedicine, synthetic biology, stem cell research and agricultural biotechnology. Jon spent 20 in network TV news, including as Tom Brokaw’s longtime producer and [...]

Jon Entine2018-06-11T09:27:00-07:00

David Younger

2018-05-16T14:02:28-07:00

David Younger, CEO of A-Alpha Bio David Younger is the Co-Founder and CEO of A-Alpha Bio, which provides high-throughput and quantitative characterization of protein-protein interactions for industry and academic applications. During his PhD, he worked with David Baker and Eric Klavins to develop synthetic biology tools that remove the experimental characterization bottleneck [...]

David Younger2018-05-16T14:02:28-07:00

Robert Friedman

2018-05-14T10:40:45-07:00

Robert Friedman, Vice President for Policy and University Relations at JCVI Robert Friedman, Ph.d. is Vice President for Policy and University Relations at the J. Craig Venter Institute (JCVI).  JCVI is a not-for-profit research institute dedicated to the advancement of the science of genomics and related disciplines.  Friedman directs JCVI’s Policy Center, [...]

Robert Friedman2018-05-14T10:40:45-07:00

Dominique Waddoup

2018-05-09T14:40:10-07:00

Dominique Waddoup, Co-founder of BirdShades Dominique is co-founder and initiator of BirdShades - a startup project with the aim to save birds from deadly window collisions. Together with Bettina Kain she is developing a transparent coating for glass surfaces which is noticeable for birds and thus stops them of flying into windows. [...]

Dominique Waddoup2018-05-09T14:40:10-07:00

Greg Scott

2018-05-01T13:25:13-07:00

Greg Scott, Founder and Chairman of ChinaBio Greg founded ChinaBio® Group in 2007 to help life science companies and investors achieve success in China. ChinaBio® works with US, European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China. ChinaBio® has also organized over 30 conferences in China focused on [...]

Greg Scott2018-05-01T13:25:13-07:00

Navjot Singh

2018-07-03T09:51:50-07:00

Navjot Singh, Managing Partner of McKinsey & Company Dr. Navjot Singh is a leader in McKinsey's Pharmaceuticals and Medicals practice and Public Sector Practice. He is the Managing Partner of the Boston Office and the Leader of the State & Local Public Sector Practice in N. America. His work is focused on [...]

Navjot Singh2018-07-03T09:51:50-07:00

Travis Whitfill

2018-04-23T11:12:06-07:00

Travis Whitfill, CSO of Azitra Travis Whitfill is the Chief Science Officer of Azitra Inc. His background began in molecular biology and biochemistry after receiving scientific training at the MD Anderson Cancer Center and Duke University. He has co-founded several biotech and healthcare startups companies, including Azitra. Mr. Whitfill’s strong background in [...]

Travis Whitfill2018-04-23T11:12:06-07:00

Benjamin Borgo

2018-04-12T15:52:06-07:00

Benjamin Borgo, Sales Manager at Agilent Technologies Ben has been at Agilent for 3 years managing product portfolios focused on advanced applications of Agilent’s technologies. His first exposure to CRISPR-based genome editing was as a graduate student where he attempted to engineer split variants of the Cas9 nuclease. Though he met with [...]

Benjamin Borgo2018-04-12T15:52:06-07:00